Indivior shares drop 11 per cent after profits fall

Listen to this article

00:00
00:00

Litigation hurts.

Shares in Indivior are down 11 per cent in early trading after the UK pharmaceutical company earlier revealed a 57 per cent drop in operating profit in 2016 after taking an impairment relating to its ongoing legal issues in the US.

The addiction drug specialist, which was spun off from Reckitt Benckiser in 2014, also warned that the final cost of the litigation could be “materially higher” than the $220m reserve it had put aside so far.

Copyright The Financial Times Limited 2017. All rights reserved. You may share using our article tools. Please don't copy articles from FT.com and redistribute by email or post to the web.